Quick Answer
BIO-RAD LABORATORIES, INC. reported Research And Development Expense of $275.60 million for the year ending 2025.
- BIO-RAD LABORATORIES, INC. showed a decrease of -6.9% in Research And Development Expense from 2024 to 2025.
- This data is from BIO-RAD LABORATORIES, INC.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $42.87 million | Q1 2011: $42.73 million | Q2 2011: $48.21 million | Q3 2011: $45.39 million | Q1 2012: $52.92 million | Q2 2012: $52.34 million | Q3 2012: $47.80 million | Q1 2013: $50.34 million | Q2 2013: $51.84 million | Q3 2013: $52.92 million | Q1 2014: $52.54 million | Q2 2014: $55.72 million | Q3 2014: $52.79 million | Q1 2015: $47.20 million | Q2 2015: $46.55 million | Q3 2015: $43.34 million | Q1 2016: $48.60 million | Q2 2016: $49.80 million | Q3 2016: $49.90 million | Q4 2016: $57.60 million | Q1 2017: $49.45 million | Q2 2017: $62.59 million | Q3 2017: $62.08 million | Q4 2017: $76.10 million | Q1 2018: $49.43 million | Q2 2018: $47.45 million | Q3 2018: $49.25 million | Q1 2019: $47.58 million | Q2 2019: $50.12 million | Q3 2019: $47.94 million | Q1 2020: $49.30 million | Q2 2020: $51.98 million | Q3 2020: $59.55 million | Q1 2021: $73.91 million | Q2 2021: $63.39 million | Q3 2021: $64.48 million | Q1 2022: $59.54 million | Q2 2022: $64.35 million | Q3 2022: $66.81 million | Q1 2023: $74.95 million | Q2 2023: $65.04 million | Q3 2023: $43.54 million | Q1 2024: $66.40 million | Q2 2024: $58.90 million | Q3 2024: $91.00 million | Q1 2025: $73.50 million | Q2 2025: $60.50 million | Q3 2025: $71.30 million.
- Over the full 18 years of available data (2008 to 2025), BIO-RAD LABORATORIES, INC.'s Research And Development Expense has grown by 72.8%.
- Historical annual values: Fiscal year 2025: $275.60 million | Fiscal year 2024: $295.90 million | Fiscal year 2023: $247.40 million | Fiscal year 2022: $256.90 million | Fiscal year 2021: $260.64 million | Fiscal year 2020: $217.76 million | Fiscal year 2019: $202.71 million | Fiscal year 2018: $199.20 million | Fiscal year 2017: $250.16 million | Fiscal year 2016: $205.71 million | Fiscal year 2015: $192.97 million | Fiscal year 2014: $220.33 million | Fiscal year 2013: $210.95 million | Fiscal year 2012: $209.20 million | Fiscal year 2011: $177.60 million | Fiscal year 2010: $172.27 million | Fiscal year 2009: $163.59 million | Fiscal year 2008: $159.52 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: